About qilian international holding group ltd. - BGM
BGM Group Ltd. is a pharmaceutical and chemical company. It focuses on the research, development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The Licorice products include Gan Di Xin, Qilian Shan Licorice Extract, and Qilian Shan Licorice Liquid Extract. The Oxytetracycline products consists of Qilian Shan Oxytetracycline Tablets and Qilian Shan Oxytetracycline Active Pharmaceutical Ingredients (API). The TCMD product includes Ahan antibacterial paste, which is made from a mixture of traditional Chinese herbal ingredients. The heparin product includes Heparin Sodium Preparations. The Sausage Casings products include Zhu Xiaochang Sausage Casings, which are all-natural food products used for culinary purposes. The Fertilizer products is composed of Xiongguan Organic Fertilizer and Xiongguan Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.
BGM At a Glance
BGM Group Ltd.
No. 152 Hongliang East
Chengdu, Sichuan 610200
| Phone | 86-28-64775180 | Revenue | 25.10M | |
| Industry | Pharmaceuticals: Major | Net Income | -1,442,830.00 | |
| Sector | Health Technology | Employees | 323 | |
| Fiscal Year-end | 09 / 2025 | |||
| View SEC Filings |
BGM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.301 |
| Price to Book Ratio | 1.351 |
| Price to Cash Flow Ratio | 96.169 |
| Enterprise Value to EBITDA | 60.803 |
| Enterprise Value to Sales | 1.632 |
| Total Debt to Enterprise Value | N/A |
BGM Efficiency
| Revenue/Employee | 77,702.635 |
| Income Per Employee | -4,466.966 |
| Receivables Turnover | 4.948 |
| Total Asset Turnover | 0.481 |
BGM Liquidity
| Current Ratio | 3.392 |
| Quick Ratio | 2.725 |
| Cash Ratio | 2.067 |
BGM Profitability
| Gross Margin | 11.465 |
| Operating Margin | -2.246 |
| Pretax Margin | -8.515 |
| Net Margin | -5.749 |
| Return on Assets | -2.768 |
| Return on Equity | -3.374 |
| Return on Total Capital | -3.376 |
| Return on Invested Capital | -3.373 |
BGM Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | N/A |
| Total Debt to Total Assets | N/A |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |